Dianthus Therapeutics, Inc. /DE/ (DNTH) /
The revenue of Dianthus Therapeutics, Inc. /DE/ over the past 10 years
Chart Dianthus Therapeutics, Inc. /DE/: revenue, fiscal 2016–2025 Open the chart →Dianthus Therapeutics, Inc. /DE/ reported revenue of $2.04M in fiscal 2025, the latest fiscal year on file. In fiscal 2016 it was $0. Year over year, revenue rose once and fell once. In these years the highest was $6.24M in fiscal 2024. The largest one-year move was in fiscal 2024: up 121%, from $2.83M to $6.24M. No revenue figure is on file for fiscal 2020, 2021 and 2022.
Year by year
| Fiscal year | Revenue |
|---|---|
| 2025ended Dec 31, 2025 | $2.04M |
| 2024ended Dec 31, 2024 | $6.24M |
| 2023ended Dec 31, 2023 | $2.83M |
| 2022ended Dec 31, 2022 | — |
| 2021ended Dec 31, 2021 | — |
| 2020ended Dec 31, 2020 | — |
| 2019ended Dec 31, 2019 | $0 |
| 2018ended Dec 31, 2018 | $0 |
| 2017ended Dec 31, 2017 | $0 |
| 2016ended Dec 31, 2016 | $0 |
Fiscal years as Dianthus Therapeutics, Inc. /DE/ reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on Dianthus Therapeutics, Inc. /DE/
- The profitability of Dianthus Therapeutics, Inc. /DE/
- The cash flow of Dianthus Therapeutics, Inc. /DE/
- The debt of Dianthus Therapeutics, Inc. /DE/
- All of Dianthus Therapeutics, Inc. /DE/'s financials, charted
Companies of a similar size
- EPREPR PROPERTIES
- PAYPaymentus Holdings, Inc.
- IESCIES Holdings, Inc.
- HRIHERC HOLDINGS INC.
- GNTXGENTEX CORPORATION
Not investment advice. This page shows what Dianthus Therapeutics, Inc. /DE/ filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.